Sinopharm Group Co. Ltd.
SHTDY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3,457,714 | $3,345,808 | $3,703,875 | $4,949,321 |
| Dep. & Amort. | $2,233,388 | $2,403,785 | $2,329,907 | $2,310,483 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $61,369,176 | -$61,369,176 | $61,205,019 |
| Other Non-Cash | -$39,802,191 | -$14,579,091 | $14,341,726 | -$7,965,369 |
| Operating Cash Flow | -$34,111,089 | $52,539,678 | -$40,993,668 | $60,499,454 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$670,699 | -$1,437,558 | -$1,023,132 | -$659,865 |
| Net Acquisitions | $0 | $102,007 | -$102,007 | $42,541 |
| Inv. Purchases | $0 | $0 | $0 | $61,507 |
| Inv. Sales/Matur. | $0 | $0 | $0 | -$150,492 |
| Other Inv. Act. | $139,455 | -$1,376,856 | $86,626 | -$251,079 |
| Investing Cash Flow | -$531,244 | -$2,712,407 | -$1,038,513 | -$957,387 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $18,713,582 | $0 | $23,868,968 | -$25,179,500 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$2,143,237 | -$2,714,862 | -$2,340,242 | -$2,558,837 |
| Other Fin. Act. | -$991,343 | -$36,121,925 | $23,031 | -$1,201,621 |
| Financing Cash Flow | $15,579,003 | -$38,836,787 | $21,551,757 | -$28,939,958 |
| Forex Effect | -$11,891 | -$8,892 | $3,652 | -$3,071 |
| Net Chg. in Cash | $35,238,139 | -$43,331,766 | $43,331,766 | $30,548,347 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $43,331,766 | $0 | $33,260,191 |
| End Cash | $35,238,139 | $54,313,359 | $43,331,766 | $63,808,538 |
| Free Cash Flow | -$34,781,788 | $51,102,120 | -$42,016,800 | $59,259,258 |